Synthesis and in vitro cytotoxic activity of compounds with pro-apoptotic potential

Gisell Apicela Soares1, Renata Barbosa de Oliveira, Saulo Fernandes de Andrade

  • 1Laboratório de Química de Produtos Naturais, Centro de Pesquisas René Rachou, Fundação Oswaldo Cruz (FIOCRUZ), Av. Augusto de Lima 1715, Belo Horizonte, MG 30190-002, Brazil.

Insights

Researchers evaluated novel compounds for anticancer activity. Two compounds demonstrated significant cytotoxic effects and induced apoptosis in cancer cell lines, showing promise for new cancer therapies.

Area of Science:

  • Medicinal Chemistry
  • Cancer Biology
  • Pharmacology

Background:

  • The development of novel anticancer therapies is crucial for combating cancer.
  • In vitro screening of synthesized compounds is a key step in drug discovery.

Purpose of the Study:

  • To evaluate the in vitro cytotoxic activity of newly synthesized compounds against cancer cell lines.
  • To assess the apoptosis-inducing potential of compounds exhibiting cytotoxicity.

Main Methods:

  • Cytotoxicity assays were performed on UACC-62 (melanoma) and JURKAT (human lymphoma) cell lines.
  • Apoptosis assays were conducted on compounds that demonstrated significant cytotoxic effects.

Main Results:

  • Two synthesized compounds exhibited notable cytotoxic activity against the tested cancer cell lines.
  • These compounds also induced apoptosis, a key mechanism in cancer cell death.

Conclusions:

  • The evaluated compounds show potential as candidates for novel anticancer drug development.
  • Further investigation into these compounds is warranted for their therapeutic application.

Related Concept Videos

The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Apoptosis01:30

Apoptosis

Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size reduction of the tissue.
Mutagenicity and Carcinogenicity01:25

Mutagenicity and Carcinogenicity

Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...